Navigation Links
TNF-Alpha Inhibitors Are Being Used More Often To Treat Newly Diagnosed Patients With Crohn's Disease
Date:12/9/2009

WALTHAM, Mass., Dec. 9 /PRNewswire/ -- Decision Resources, one of the world's leading research and advisory firms focusing on pharmaceutical and healthcare issues, finds that compared to last year's analysis of U.S. patient-level claims data, TNF-alpha inhibitors are being used more often to treat newly diagnosed patients suffering from Crohn's disease. Three times as many newly diagnosed second-line patients received a TNF-alpha inhibitor versus one year ago (15.2 percent versus 5.6 percent). This boost is due in part to physicians' increased prescribing of Centocor Ortho Biotech's Remicade as a second- or third-line therapy for newly diagnosed patients.

"Our analysis of patient-level claims data shows that both Remicade and Abbott's Humira contributed to the increased uptake of TNF-alpha inhibitors in newly diagnosed patients. However, Remicade outpaces Humira substantially in second- and third-line treatment for these patients," stated Madhuri Borde, Ph.D., product director at Decision Resources. "While enthusiasm for agents with self-administration (e.g., Humira, UCB's Cimzia) may lead to slower growth for Remicade in the future, our survey results make it clear that physicians prescribe Remicade based on its perceived superior efficacy in inducing remission and in healing fistulizing forms of Crohn's disease compared with Humira and Cimzia."

The new Treatment Algorithms in Crohn's Disease report also finds that a major shift in U.S. gastroenterologists' prescribing patterns will occur over the next two years. More than 60 percent of U.S. surveyed gastroenterologists will increase their use of a top-down approach to treating Crohn's disease in newly diagnosed patients (i.e. starting with a biologic) and more than 70 percent will decrease their use of corticosteroids in newly diagnosed patients.

By combining patient-level claims data with physician survey data, this report can be used to build p
'/>"/>

SOURCE Decision Resources
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Cytokine Demonstrates Oral Efficacy of Small-Molecule MIF Inhibitors
2. Oncology Drugs Development Update - Worldwide Markets and Forecasts of Approved EGFr/HEr2 Inhibitors, Treatment Costs, Pathway Analysis, Current and Expanded Clinical Indications, and Novel Agents in Development
3. AngioGenex Files Patent on First Small Molecule Id-Inhibitors for the Treatment of Cancer
4. Telik Announces Presentation of Preclinical Data on Dual Inhibitors of Aurora Kinases and VEGFR2
5. Telik Announces Preclinical Data Demonstrating Anti-Cancer Activity of Dual Inhibitors of Aurora Kinase and VEGFR2
6. Potent Hepatitis C Virus Inhibitors Show Efficacy and Potential for Once Daily Dosing in Preclinical Studies
7. Ardea Biosciences Presents Preclinical Data Demonstrating Favorable Resistance Profiles for Non-Nucleoside Reverse Transcriptase Inhibitors for the Treatment of Human Immunodeficiency Virus
8. Pharmacyclics Reports Multiple Presentations at AACR on Its HDAC and Selective HDAC Inhibitors
9. Ardea Biosciences Presents Data Demonstrating Favorable Pharmacokinetics and Efficacy for Mitogen-Activated ERK Kinase (MEK) Inhibitors
10. Kosan Presents Preclinical Data on Nuclear Export Inhibitors, Novel Anticancer Agents, at AACR
11. Poniard Pharmaceuticals Licenses Kinase Inhibitors From The Scripps Research Institute
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/17/2014)... , Sept. 17, 2014  Auxilium Pharmaceuticals, Inc. ... today confirmed that Auxilium has received an unsolicited, non-binding ... ) to acquire all of the outstanding shares of ... share in cash and Endo stock, subject to due ... unsolicited, non-binding proposal that Auxilium received from Endo on ...
(Date:9/16/2014)... 2014 Hologic, Inc. (NASDAQ: ... Europa del Tomcat, un nuovo strumento preanalitico marcato ... completamente automatizzata, progettata per semplificare la fase preanalitica ... di errore legati alla gestione manuale dei campioni. ... Hologic riduce il carico di lavoro legato al ...
(Date:9/16/2014)... 3SBio Inc., ("3SBio") a leading biotechnology ... focusing on researching, developing, manufacturing and marketing biopharmaceutical ... an exclusive license agreement with JenKem Technology Co., ... in Mainland China of PEG-irinotecan, a long-acting polymer-drug ... over-expressed in many solid tumors, including colorectal, ovarian, ...
Breaking Medicine Technology:Auxilium Responds To Unsolicited Proposal From Endo International 2Auxilium Responds To Unsolicited Proposal From Endo International 3Auxilium Responds To Unsolicited Proposal From Endo International 4Auxilium Responds To Unsolicited Proposal From Endo International 5Auxilium Responds To Unsolicited Proposal From Endo International 6Auxilium Responds To Unsolicited Proposal From Endo International 7Hologic annuncia il lancio dello strumento preanalitico Tomcat in Europa 2Hologic annuncia il lancio dello strumento preanalitico Tomcat in Europa 33SBio Inc. obtains exclusive licenses to develop and market JenKem's PEG-Irinotecan in China 23SBio Inc. obtains exclusive licenses to develop and market JenKem's PEG-Irinotecan in China 33SBio Inc. obtains exclusive licenses to develop and market JenKem's PEG-Irinotecan in China 43SBio Inc. obtains exclusive licenses to develop and market JenKem's PEG-Irinotecan in China 5
... CarePoint Partners (CarePoint) today announced that it has ... pharmacy services in Austin, Texas and infusion pharmacy ... area. The Austin location complements CarePoint,s Dallas and ... its southeastern footprint with this expansion into the ...
... Hospira, Inc. (NYSE: HSP ), a leading ... the company will present at the Bank of America / ... 2011, in Las Vegas. The presentation is scheduled ... 11, 2011.  It will be available to all interested parties ...
Cached Medicine Technology:CarePoint Partners Expands Texas Presence and Opens Georgia Market With Acquisition of Premier Infusion 2
(Date:9/17/2014)... 2014 Health.Verticalize, a healthcare marketing company ... health insurance options in the 2014 open enrollment period, ... Moving forward Health Network will be using ... has intentionally remained out of the spotlight for the ... single website to its present position with dozens of ...
(Date:9/17/2014)... Presence Technology, a multinational provider of ... 10.0, which incorporates significant enhancements to meet the ... The Contact Center Agents and Supervisors will have ... a better feel for the performance of their ... who requires additional coaching or mentoring to raise ...
(Date:9/16/2014)... Although more and more people are being affected ... the true daily struggle of the disease. But one ... rob a person of their memory, it takes their ... Forget to Tell You ” (published by Xlibris) shares ... loved one who is suffering from Alzheimer’s disease. Her ...
(Date:9/16/2014)... 17, 2014 Top10BestSEOHosting.com has recently ... most recommended companies for the webmasters that want ... rates. , The senior spokesman for Top10BestSEOHosting.com ... Bluehost and HostMonster are the excellent hosting companies ... provide a wide range of advanced features while ...
(Date:9/16/2014)... Dog Food Secrets , a guide compiled by ... in most commercial dog food but presents a better alternative ... Shane Michaels, prompting an investigative review. , “For most ... member as any other human is, which is why it’s ... due to poor diet” reports Michaels. “Most dog owners don’t ...
Breaking Medicine News(10 mins):Health News:Health.Verticalize Rebrands as Health Network After Growing to 15 Million Users in Less Than One Year 2Health News:Health.Verticalize Rebrands as Health Network After Growing to 15 Million Users in Less Than One Year 3Health News:Presence Technology’s 10.0 Release Drives Contact Center Web Supervisor Effectiveness While Reducing Operation Costs and Delivering Enterprise Grade Scalability 2Health News:Author shares personal journey about her mother’s Alzheimer’s disease 2Health News:Author shares personal journey about her mother’s Alzheimer’s disease 3Health News:Top10BestSEOHosting.com: Arvixe Is One Of The Best SEO Hosting Suppliers 2Health News:Dog Food Secrets: Review Exposes Andrew Lewis’ Guide to Happier, Healthier Dogs with Homemade Dog Food 2
... ... , ... 24, 2010 -- At just over 18 pounds and with a sound level of only ... lighter and quieter than its battery-operated competitors. Powered by a lithium ion battery with 30 ...
... halt, expert says , TUESDAY, March 23 (HealthDay News) ... trials that are stopped early due to encouraging results, ... of 91 truncated trials with 424 comparable full-length trials, ... in particular, smaller studies -- reported exaggerated or misleading ...
... Walking, biking, dancing can all help normal-weight women as they ... An hour a day of moderate-intensity exercise will prevent weight ... a new study. , ",Moderate intensity, means brisk walking, casual ... Lee, lead author of the study, which is published in ...
... , BOSTON , March 23 ... current ESPN analyst Tedy Bruschi ... Trustees of Partners Continuing Care, the non-acute division of ... Partners Home Care, Partners Continuing Care offers the full ...
... America today hailed the "Patient Protection and Affordable Care Act" signed by the President today. The legislation will greatly expand access to mental health care ... ... , , ... ...
... , March 23 The Alzheimer,s Foundation of America issued the following statement on the health reform legislation that was signed into law today by President Obama:   , ... , ... ... ...
Cached Medicine News:Health News:Advance Introduces the Adgility™ XPB Battery Backpack Vacuum – the Lightest in the Industry, 2Health News:Abbreviated Trials Yield Misleading Results: Study 2Health News:Being Active an Hour a Day Puts Brakes on Weight Gain 2Health News:Being Active an Hour a Day Puts Brakes on Weight Gain 3Health News:Tedy Bruschi Joins the Board of Trustees for Partners Continuing Care and Spaulding Rehabilitation Network 2Health News:Tedy Bruschi Joins the Board of Trustees for Partners Continuing Care and Spaulding Rehabilitation Network 3Health News:Mental Health America Hails Enactment of Historic Health Care Reform Bill 2Health News:Mental Health America Hails Enactment of Historic Health Care Reform Bill 3Health News:Alzheimer's Foundation of America Hails Significant Provisions for Dementia Community in Health Reform Law 2Health News:Alzheimer's Foundation of America Hails Significant Provisions for Dementia Community in Health Reform Law 3Health News:Alzheimer's Foundation of America Hails Significant Provisions for Dementia Community in Health Reform Law 4
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
Medicine Products: